DHEA-sulfate (commonly written DHEAS or DHEA-S) is the most abundant steroid hormone circulating in your blood, produced almost entirely by the adrenal glands. It serves as a precursor that your tissues convert into active sex hormones, and its levels follow a distinctive arc over a lifetime: rising sharply in childhood, peaking in your twenties, then declining steadily for decades. That decline has made DHEAS one of the most studied hormones in aging research, with links to bone density, cardiovascular health, brain function, metabolic fitness, and resilience to stress. Yet the relationship between DHEAS levels and actual health outcomes turns out to be more complicated than the supplement industry suggests.
Where DHEAS Comes From
Your adrenal glands sit atop each kidney and are organized in layers. The innermost layer, called the zona reticularis, is the primary factory for DHEA and DHEAS. Production depends on specific enzymes in that zone, particularly a sulfotransferase called SULT2A1 and a protein called cytochrome b5 (CYB5), which together determine how much DHEA gets converted into the sulfated form and released into your bloodstream.1PubMed Central. Regulation of the adrenal androgen biosynthesis The sulfate tag matters: it makes DHEAS water-soluble, gives it a much longer half-life (hours rather than minutes), and allows it to circulate as a stable reservoir that tissues can tap into when they need active hormones.
Humans and a handful of other primates are unusual in this regard. Most mammals produce very little DHEAS. Among primates, chimpanzees come closest to matching our levels and age-related pattern, while gorillas show a shorter-lived spike earlier in development.2PubMed Central. Adrenal androgen production in catarrhine primates and the evolution of adrenarche This evolutionary quirk is part of why DHEAS research done in mice or rats has been hard to translate to humans: rodents simply don’t have a comparable hormonal system.
The Lifetime Rise and Fall
DHEAS levels climb during a phase called adrenarche, usually starting around ages six to eight, well before puberty begins. They continue rising until roughly the mid-twenties, when concentrations reach their lifetime peak. After that, levels drop by roughly two to three percent per year. By the time you reach your seventies or eighties, circulating DHEAS may be only ten to twenty percent of what it was at its peak. This gradual decline is sometimes called “adrenopause,” and it happens in both sexes, though the timeline differs somewhat.
In women, a meaningful drop appears to start earlier than many clinicians assumed. Research tracking DHEAS across age groups found that a significant decrease occurred in women between ages 41 and 45, with more than a third of women over 40 falling below a proposed threshold level.3PubMed Central. From adrenarche to aging of adrenal zona reticularis: precocious female adrenopause onset This earlier “adrenopause” in women has implications for how we think about sex-hormone availability after menopause, since DHEAS is one of the main raw materials from which postmenopausal women’s bodies still manufacture estrogen and testosterone locally.
How Your Tissues Actually Use DHEAS
DHEAS itself is not particularly active. Its value lies in what it becomes. Your peripheral tissues, including skin, bone, fat, muscle, and brain, contain the enzymes needed to strip off the sulfate group and convert DHEA into potent androgens and estrogens right where they are needed. This process is called intracrinology: the hormones are made, used, and broken down inside the target tissue itself, without flooding the general circulation with active sex steroids.4PubMed. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging
This local conversion is especially important in women, who manufacture almost all of their androgens from DHEA and DHEAS within target tissues. A study applying DHEA through the skin demonstrated that physiological doses allowed local androgen production without causing meaningful increases in circulating testosterone or estrogen levels.5The Journal of Clinical Endocrinology & Metabolism. Physiological Changes in Dehydroepiandrosterone Are Not Reflected by Serum Levels of Active Androgens and Estrogens But of Their Metabolites: Intracrinology In practical terms, this means that measuring someone’s blood levels of testosterone or estrogen does not fully capture the androgenic or estrogenic activity happening in their tissues when DHEAS supply changes. The intracrine system is, by design, somewhat invisible to standard blood tests.
DHEAS, Skin, and Androgens
One of the most visible sites where DHEAS gets converted into active hormones is the skin. Your skin possesses the full enzyme toolkit to turn circulating DHEAS and androstenedione into testosterone and its more potent derivative, dihydrotestosterone (DHT). These locally produced androgens influence sebaceous gland size and oil production, hair growth patterns, wound healing, and the integrity of the skin’s barrier function. This is why conditions like acne and hirsutism are often tied to adrenal androgen output, and why elevated DHEAS in blood work can be a clue in evaluating these complaints.
When DHEAS is abnormally elevated in women, clinicians typically want to rule out conditions like non-classic congenital adrenal hyperplasia (NCAH), a genetic condition where enzyme deficiencies redirect steroid production. In one reported case of NCAH, DHEAS and testosterone were only mildly elevated, but DHT was disproportionately high because of an alternative “backdoor” androgen pathway, a reminder that DHEAS alone does not tell the full story of androgen exposure.6PubMed Central. Non-Classic Disorder of Adrenal Steroidogenesis and Clinical Dilemmas in 21-Hydroxylase Deficiency Combined with Backdoor Androgen Pathway. Mini-Review and Case Report
The Cortisol-to-DHEAS Ratio and Stress
DHEAS does not operate in isolation. It shares the adrenal production line with cortisol, the body’s primary stress hormone, and the ratio between the two has become a focus of aging and stress research. Both are regulated upstream by the same signaling hormone, ACTH, but they trend in opposite directions as you age: cortisol stays roughly stable or rises slightly, while DHEAS drops. The result is that the cortisol-to-DHEAS ratio climbs progressively through midlife and beyond.
This shifting ratio appears to have real biological consequences. Research on epigenetic aging clocks found that the cortisol-to-DHEAS ratio was a better predictor of accelerated biological aging than either hormone measured alone.7PubMed Central. Cortisol, DHEAS, and the cortisol/DHEAS ratio as predictors of epigenetic age acceleration And people reporting high perceived stress at work show a blunted DHEAS response during acute stress testing, meaning their adrenals pump out plenty of cortisol but fail to ramp up DHEAS proportionally.8PubMed. Perceived stress at work is associated with attenuated DHEA-S response during acute psychosocial stress Chronic stress appears to worsen this imbalance, and some researchers have proposed the cortisol-to-DHEAS ratio as a useful biomarker for gauging long-term stress exposure and its downstream effects on insulin sensitivity.9AR-RUMMAN: Journal of Education and Learning Evaluation. Literature Study: Cortisol Hormone to DHEA-S Ratio as an Indicator of HPA Axis Activity in Chronic Stress and Insulin Resistance
Frailty in older adults also tracks with this imbalance. A ten-year longitudinal study of community-dwelling older people found that lower baseline DHEAS and a higher cortisol-to-DHEAS ratio were both associated with greater odds of becoming frail.10PubMed Central. Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people In men specifically, higher DHEAS was linked to lower frailty risk, but in a large European study this association lost statistical significance once age was accounted for, except in men over 70, where higher DHEAS did independently predict less worsening.11The Journal of Clinical Endocrinology & Metabolism. Nonandrogenic Anabolic Hormones Predict Risk of Frailty: European Male Ageing Study Prospective Data The honest takeaway is that DHEAS levels are deeply entangled with age itself, making it difficult to separate cause from marker.
Metabolic and Cardiovascular Connections
Higher DHEAS levels tend to correlate with better metabolic profiles, though the relationship is not always straightforward. In women with polycystic ovary syndrome (PCOS), where androgen levels are typically elevated, DHEAS stands out as an exception to the usual picture: it is negatively correlated with insulin resistance. In one analysis, DHEAS ranked just behind body mass index, waist-to-hip ratio, and age as a predictor of insulin sensitivity, and higher DHEAS was associated with lower insulin resistance even after adjusting for other androgens.12PubMed Central. Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome In aging men, a study of metabolic syndrome found that higher DHEAS was inversely associated with the syndrome in basic analysis, though the strength of that association was modest compared to testosterone and sex hormone-binding globulin.13The Journal of Clinical Endocrinology & Metabolism. Endogenous Sex Hormones and Metabolic Syndrome in Aging Men
On the cardiovascular side, the interest centers on DHEAS’s apparent anti-inflammatory properties. In laboratory experiments with human aortic endothelial cells, DHEAS suppressed the inflammatory cascade triggered by TNF-alpha, reducing the expression of key adhesion molecules and inflammatory signals that drive the early stages of atherosclerosis. This effect worked through activation of a receptor called PPARα and inhibition of NF-κB, a central inflammatory switch.14PubMed Central. Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB In a rabbit model of arterial injury, DHEAS also reduced the abnormal thickening of blood vessel walls that follows damage, slowing the proliferation and migration of smooth-muscle cells.15PubMed Central. Adrenal Androgen Dehydroepiandrosterone Sulfate Inhibits Vascular Remodeling Following Arterial Injury These are encouraging mechanisms, but they are lab and animal findings. Large-scale clinical trials proving that raising DHEAS prevents heart attacks or strokes in humans do not yet exist.
DHEAS and the Brain
DHEAS is classified as a neurosteroid, meaning it is active in the brain and can be produced there locally as well as arriving via the bloodstream. It modulates a receptor called NMDA, which is central to learning, memory, and neural plasticity. Experiments show that DHEAS allosterically changes how the NMDA receptor behaves at concentrations matching those found naturally in the body.16PubMed. The effect of dehydroepiandrosterone sulfate and allopregnanolone sulfate on the binding of [(3)H]ifenprodil to the N-methyl-d-aspartate receptor in rat frontal cortex membrane
In terms of cognition, the picture is mixed. Observational studies have found a positive correlation between DHEAS blood levels and global cognition in both sexes, with additional associations to working memory, attention, and verbal fluency in women specifically.17PubMed Central. Dehydroepiandrosterone, Its Sulfate and Cognitive Functions But correlation is not causation, and when researchers have actually given DHEA to elderly volunteers, the results have been underwhelming for cognitive endpoints. An older review concluded that cross-sectional data hinted at links to well-being and functioning, but experimental studies failed to find clear improvements in memory or attention.18PubMed. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans
Where DHEA may have more promise is mood regulation. Neuroimaging research found that DHEA administration reduced activity in the amygdala and hippocampus while enhancing connectivity between them and boosting activity in a brain region linked to emotional regulation. Participants also reported reduced negative emotions.19PubMed Central. DHEA Enhances Emotion Regulation Neurocircuits and Modulates Memory for Emotional Stimuli These findings have been framed as early evidence that DHEA might eventually play a role in treating mood and anxiety disorders, but that remains investigational.
Bone Density and Muscle Strength
DHEAS has a well-documented relationship with bone health, particularly in women. A Mendelian randomization study, which uses genetic variants as a natural experiment to test causal relationships, found that a genetically driven increase in DHEAS was causally linked to higher lumbar spine bone mineral density in women and a roughly 30 percent reduction in forearm fracture risk.20The Journal of Clinical Endocrinology & Metabolism. Endogenous DHEAS Is Causally Linked With Lumbar Spine Bone Mineral Density and Forearm Fractures in Women This genetic evidence is stronger than typical observational data because it is less likely to be confounded by other lifestyle or health factors.
When DHEA is given as a supplement, the bone effects are modest. A twelve-month trial in older adults found a small but statistically significant increase in lumbar spine bone density in women, though no effect at the hip, femoral neck, or total body, and no benefit at any site in men.21PubMed Central. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults the DAWN trial For muscle strength, observational data show that older adults with higher DHEAS tend to have greater muscle mass and grip strength, with the association holding more clearly in women than in men after adjustment.22PubMed. Dehydroepiandrosterone Sulfate and Free Testosterone but not Estradiol are Related to Muscle Strength and Bone Microarchitecture in Older Adults
Prostate Cancer and DHEAS in Men
The relationship between androgens and prostate cancer is often oversimplified in popular health discussions. A large prospective study found that the risk of aggressive prostate cancer actually decreased as DHEAS levels rose. Doubling the concentration of DHEAS was associated with about a 37 percent lower risk of aggressive disease, with similar protective trends seen for testosterone and androstenedione. Meanwhile, there was essentially no relationship between these hormones and non-aggressive prostate cancer.23Cancer Epidemiology, Biomarkers & Prevention. Circulating Steroid Hormones and the Risk of Prostate Cancer This finding runs counter to the old assumption that more androgens automatically mean more prostate cancer risk, and it underscores the complexity of hormonal influences on cancer biology.
What DHEA Supplementation Actually Does
DHEA is sold over the counter in many countries and is one of the most popular anti-aging supplements. Blood levels of both DHEA and DHEAS rise in a dose-dependent manner with supplementation, though the increase appears to plateau at doses above about 300 milligrams per day. Doses above 50 milligrams per day typically push levels to or above the upper limit of normal for young adults.24PubMed. Correlation between the administered dose of DHEA and serum levels of DHEA and DHEA-S in human volunteers: analysis of published data
The downstream hormonal effects depend on dose and age. A meta-analysis of randomized controlled trials in postmenopausal women found that DHEA at 50 milligrams per day or more significantly raised both testosterone and estradiol levels. But doses below 50 milligrams per day did not produce statistically meaningful changes in either hormone. Women aged 60 and older showed a more pronounced rise in estradiol compared to younger postmenopausal women.25PubMed Central. Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects Supplementation also raises androstenedione.26PubMed. Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids
What this means practically is that DHEA supplementation is not hormonally inert. In postmenopausal women it functions as a mild source of both androgens and estrogen, which is relevant for anyone with a history of hormone-sensitive cancer or who is taking medications designed to lower estrogen. Treating it as a casual wellness supplement, as marketing often encourages, overlooks these real endocrine effects.
Medications That Move DHEAS Levels
Several prescription drugs alter DHEAS concentrations, sometimes enough to confuse diagnostic testing. Glucocorticoids like dexamethasone are the most potent suppressors, working by shutting down ACTH, the pituitary hormone that drives adrenal androgen production.27Journal of Clinical Pharmacology. The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: A review of clinical studies In women with elevated adrenal androgens, very low doses of bedtime dexamethasone can suppress DHEAS effectively; most women in one study achieved suppression at just 0.25 milligrams daily, well below the doses commonly used for other conditions.28PubMed. Treatment of androgenic disorders with dexamethasone: dose-response relationship for suppression of dehydroepiandrosterone sulfate If you are taking any corticosteroid and your doctor orders a DHEAS level, the result will likely be artificially low.
Why the Test Method Matters
DHEAS is one of the more commonly ordered hormone tests, but not all assays are equally reliable. A head-to-head comparison of seven commercial immunoassays against a gold-standard mass spectrometry method found that only three of the seven agreed well with the reference, while four showed standardization problems with slopes ranging from 0.84 to 1.28, meaning results could be off by roughly 15 to 30 percent depending on which lab ran the test.29PubMed. Measurement of dehydroepiandrosterone sulphate (DHEAS): a comparison of Isotope-Dilution Liquid Chromatography Tandem Mass Spectrometry (ID-LC-MS/MS) and seven currently available immunoassays
The problem is even more pronounced in newborns and infants, where standard immunoassay platforms can overestimate DHEAS by more than 160 percent compared to mass spectrometry.30PubMed. A liquid chromatography-tandem mass spectrometry method for the analysis of dehydroepiandrosterone sulphate (DHEAs) in serum and plasma with comparison to an immunoassay method in a neonatal population For most adults getting a screening test, the standard immunoassay is adequate for rough clinical decisions. But if a result is borderline or unexpected, or if it is being used to monitor treatment, asking whether the lab used mass spectrometry is a reasonable question.
DHEAS and Polycystic Ovary Syndrome
DHEAS gets measured routinely as part of the hormonal workup for PCOS, though it is not elevated in every phenotype. The classic presentation of PCOS involves both ovarian and adrenal androgen excess, but several recognized subtypes exist. In diagnosing PCOS, clinicians also check 17-hydroxyprogesterone to rule out non-classic congenital adrenal hyperplasia, which can mimic PCOS symptoms, and sometimes measure urinary cortisol or prolactin to exclude other endocrine conditions.31PubMed Central. Increased Prevalence of Elevated DHEAS in PCOS Women with Non-Classic (B or C) Phenotypes: A Retrospective Analysis in Patients Aged 20 to 29 Years An isolated elevation in DHEAS without other signs of androgen excess is not, by itself, a diagnosis of PCOS or any other disorder. It is a starting point for further investigation.
The metabolic link mentioned earlier, where DHEAS correlates inversely with insulin resistance in PCOS patients, has led some researchers to suggest that the subgroup of PCOS women with predominantly adrenal rather than ovarian androgen excess may carry a somewhat different metabolic risk profile. This is an evolving area where phenotype-specific management is gaining traction over one-size-fits-all approaches.